These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 18273715

  • 1. Design of phase II ALS clinical trials.
    Schoenfeld DA, Cudkowicz M.
    Amyotroph Lateral Scler; 2008; 9(1):16-23. PubMed ID: 18273715
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests.
    Polley MY, Cheung YK.
    Biometrics; 2008 Mar; 64(1):232-41. PubMed ID: 17573866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A two-stage phase II trial design utilizing both primary and secondary endpoints.
    Lin X, Allred R, Andrews G.
    Pharm Stat; 2008 Mar; 7(2):88-92. PubMed ID: 17252536
    [Abstract] [Full Text] [Related]

  • 17. Opportunities for improving therapy development in ALS.
    Bruijn L, Cudkowicz M, ALS Clinical Trials Working Group.
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):169-73. PubMed ID: 24472060
    [Abstract] [Full Text] [Related]

  • 18. Phase II clinical trials in oncology: are we hitting the target?
    Ang MK, Tan SB, Lim WT.
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):427-38. PubMed ID: 20214523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.